3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Vomiting
1
Ventilator-Induced Lung Injury
1
Urologic Neoplasms
1
Urogenital Neoplasms
1
Postoperative Complications
1
Kidney Neoplasms
1
Carcinoma, Renal Cell
1
Interventions
aldesleukin
9
Sunitinib
5
Interferon-alpha
4
Chemotherapy, Adjuvant
4
pembrolizumab
3
Vincristine
3
Neoadjuvant Therapy
3
Dactinomycin
3
Cyclophosphamide
3
Bevacizumab
3
sargramostim
2
fludarabine phosphate
2
Robotic Surgical Procedures
2
Radiotherapy
2
Peripheral Blood Stem Cell Transplantation
2
Laparoscopy
2
Gene Expression Profiling
2
Fluorouracil
2
Etoposide
2
Electroporation
2
Doxorubicin
2
Carboplatin
2
Blood Specimen Collection
2
Amplified Fragment Length Polymorphism Analysis
2
tremelimumab
1
toripalimab
1
temsirolimus
1
spartalizumab
1
pazopanib
1
orantinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Kidney Neoplasms
×
Dosage Forms
×
Clear all
NCT04644432
2020-11-25
INDIGO
Herlev and Gentofte Hospital
Phase 2
Unknown
30 enrolled